During the past decade, Sociedad de Metabolismo y Corazon S.C conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 13 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sociedad de Metabolismo y Corazon S.C" #1 sponsor was "Pfizer" with 8 trials, followed by "Takeda" with 5 trials sponsored, "Allergan" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "BioNTech SE" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sociedad de Metabolismo y Corazon S.C" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sociedad de Metabolismo y Corazon S.C" are "COVID-19" (5 trials), "Gastroparesis" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Sociedad de Metabolismo y Corazon S.C" in a lesser frequency.

Most popular intervention types in "Sociedad de Metabolismo y Corazon S.C" are "Drug" (24 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Mirikizumab" (3 trials), "PF-07321332" (3 trials), "Relamorelin" (3 trials) and "Ritonavir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sociedad de Metabolismo y Corazon S.C" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Sociedad de Metabolismo y Corazon S.C". 1 are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sociedad de Metabolismo y Corazon S.C, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Sociedad de Metabolismo y Corazon S.C, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".